| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.24 |
6e-12 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
5e-11 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-10 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
7e-10 |
| mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-07 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-07 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-07 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-07 |